Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Oncology

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molonc.2009.07.003PMID 19713161PMCID PMC5527532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

  2009cited by this paper
• Triple‐negative/basal‐like breast cancer: review

  2009cited by this paper
• Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.

  2009cited by this paper
• Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models

  2009cited by this paper
• Triple-Negative Breast Cancer: Risk Factors to Potential Targets

  2008cited by this paper
• Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

  2008cited by this paper
• A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

  2007cited by this paper
• Unraveling the Mechanisms of Endocrine Resistance in Breast Cancer: New Therapeutic Opportunities

  2007cited by this paper
• HER2 and response to paclitaxel in node-positive breast cancer.

  2007cited by this paper
• Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

  2006cited by this paper
• Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

  2006cited by this paper
• Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer

  2006cited by this paper
• CGH-Explorer: a program for analysis of array-CGH data

  2005cited by this paper
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005influential reference
• Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

  2005cited by this paper
• Stromal fibroblasts in cancer initiation and progression

  2004cited by this paper
• Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

  2001cited by this paper
• Influence of TP 53 Gene Alterations and c-erbB2 Expression on the Response to Treatment with Doxorubicin in Locally Advanced Breast Cancer 1

  2001cited by this paper
• Genomic sequencing.

  1993cited by this paper
• Genomic sequencing.

  1984cited by this paper

• Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

  2026cites this paper
• Patient-Derived Xenografts of Breast Cancer.

  2025cites this paper
• Investigating proteogenomic divergence in patient-derived xenograft models of ovarian cancer

  2025cites this paper
• Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool

  2025cites this paper
• The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding

  2025cites this paper
• Human collagen type I‑based scaffold retains human‑derived fibroblasts in a patient‑derived tumor xenograft mouse model

  2024cites this paper
• Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants

  2024cites this paper
• The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy

  2024cites this paper
• FOXO1 promotes the expression of canonical WNT target genes in examined basal‐like breast and glioblastoma multiforme cancer cells

  2023cites this paper
• Liver X receptors induce antiproliferative effects in basal‐like breast cancer

  2023cites this paper
• Breast cancer patient-derived explant cultures recapitulate in vivo drug responses

  2023cites this paper
• IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.

  2023cites this paper
• A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression

  2022cites this paper
• The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery

  2022cites this paper
• Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness

  2022cites this paper
• Sporadic cell death in macroscale 3D tumor grafts with high drug resistance by activating cell-ECM interactions

  2021cites this paper
• Reproducible Lipid Alterations in Patient-Derived Breast Cancer Xenograft FFPE Tissue Identified with MALDI MSI for Pre-Clinical and Clinical Application

  2021cites this paper
• Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft

  2021cites this paper
• Polymerization as a Strategy to Improve Small Organic Matrices for Low-Molecular-Weight Compound Analytics with MALDI MS and MALDI MS Imaging

  2021cites this paper
• Patient-Derived Xenograft Models in Breast Cancer Research.

  2021cites this paper
• In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

  2021cites this paper
• Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine

  2020cites this paper
• Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1

  2020cites this paper
• The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance

  2020cites this paper
• Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer

  2020cites this paper
• Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes

  2020cites this paper
• Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.

  2019cites this paper
• Cabazitaxel‐loaded Poly(2‐ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft

  2019cites this paper
• Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis

  2019cites this paper
• Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts

  2019cites this paper
• Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer

  2019cites this paper
• The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models

  2019cites this paper
• Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation

  2019cites this paper
• Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca2+-NFAT1 Axis

  2019cites this paper
• Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis

  2019cites this paper
• Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids.

  2018cites this paper
• Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4

  2018cites this paper
• Comparative oncology research in Australia: establishing the Australian Veterinary Cancer Biobank to validate canine mammary tumours as a model for human breast cancer

  2018cites this paper
• Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts

  2017cites this paper
• MR-Derived Biomarkers for Cancer Characterization

  2017cites this paper
• Patient-Derived Xenografts in Oncology

  2017cites this paper
• Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide

  2017cites this paper
• Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis

  2017cites this paper
• Ex vivo tumor culture systems for functional drug testing and therapy response prediction

  2017cites this paper
• Effect of Glutaminase Inhibition in Basal-Like Patient-Derived Xenografts Analyzed by Magnetic Resonance Spectroscopy

  2017influential citation
• Modeling Breast Cancer Heterogeneity With Patient-Derived Xenografts

  2017cites this paper
• Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.

  2017cites this paper
• Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.

  2017cites this paper
• THE ANTI-PROLIFERATIVE ACTIVITY OF VITIS VINIFERA LEAVES OF WATER EXTRACT ALONE AND IN COMBINATION WITH DOXORUBICIN AGAINST LIVER CANCER CELL LINE.

  2017cites this paper
• Fidelity and Stability of PDX Models

  2017cites this paper
• Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts

  2017cites this paper
• AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program

  2017cites this paper
• Patient-derived tumour xenografts for breast cancer drug discovery

  2016cites this paper
• Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

  2016cites this paper
• Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX

  2016cites this paper
• Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies

  2016cites this paper
• Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization

  2016cites this paper
• Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments

  2016cites this paper
• Anti‐angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro–computed tomography angiography and dynamic contrast enhanced MRI

  2016cites this paper
• Patient‐derived xenografts as tools in pharmaceutical development

  2016cites this paper
• Anti-angiogenic therapy affects the relationship between tumor vascular structure and function : a correlation study between micro-CT angiography and DCE-MRI

  2016cites this paper
• Metabolic profiling of breast cancer using ex vivo MR spectroscopy

  2016cites this paper
• Variability of dynamic 18F-FDG-PET data in breast cancer xenografts

  2015cites this paper
• Development of Computational Methods for Cancer Research: Strategies for closing the feedback loop in omics workflows

  2015cites this paper
• In Vivo 31P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts

  2015cites this paper
• Patient-derived xenograft models of breast cancer and their predictive power

  2015cites this paper
• Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

  2015cites this paper
• Pre-Clinical Murine Models: Syngeneic Models for Immuno-Oncology

  2015cites this paper
• Breast cancer stem cells: current advances and clinical implications.

  2015cites this paper
• Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

  2014cites this paper
• Cancer cell lines for drug discovery and development.

  2014cites this paper
• Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts

  2014cites this paper
• Correction: Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and Histologic characteristics of human cancers

  2014cites this paper
• Epigenetic regulation of EMT: the Snail story.

  2014cites this paper
• Maspin influences response to doxorubicin by changing the tumor microenvironment organization

  2014cites this paper
• Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy

  2014cites this paper
• Patient-derived tumour xenografts as models for breast cancer drug development

  2014cites this paper
• Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft

  2014cites this paper
• Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

  2014cites this paper
• Quantitative 31P HR‐MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts

  2014cites this paper
• Accurate Identification of Somatic Mutations in Clinical Tumor Specimens

  2013cites this paper
• Patient-derived tumor xenografts: transforming clinical samples into mouse models.

  2013influential citation
• Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

  2013influential citation
• [Contribution to new therapeutics against colorectal cancer: the CReMEC initiative].

  2013cites this paper
• Biologically and Ethnically Diverse, Patient-Derived Human Breast A Renewable Tissue Resource of Phenotypically Stable,

  2013cites this paper
• Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers

  2013cites this paper
• Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations

  2013cites this paper
• Patient-derived breast tumor xenografts facilitating personalized cancer therapy

  2013cites this paper
• Subtype‐specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts

  2013cites this paper
• Dynamic 18F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts

  2013cites this paper
• Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics.

  2013cites this paper
• Low‐molecular contrast agent dynamic contrast‐enhanced (DCE)‐MRI and diffusion‐weighted (DW)‐MRI in early assessment of bevacizumab treatment in breast cancer xenografts

  2013cites this paper
• A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.

  2013cites this paper
• Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse

  2013cites this paper
• Dynamic 18 F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts

  2013cites this paper
• Regulation and action of SKP2 and RhoA in cell and tumor models: Investigation into the molecular mechanisms responsible for the aggressive phenotype of triple-negative breast cancer

  2013cites this paper
• Characterization and Targeting of the Aldehyde Dehydrogenase Subpopulation in Ovarian Cancer

  2013cites this paper
• Contribution au développement de nouvelles thérapies contre le cancer colorectal - L’initiative CReMEC

  2013cites this paper
• Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

  2013cites this paper
• Patient‐derived xenografts recapitulate molecular features of human uveal melanomas

  2013cites this paper